as on September 17, 2025 at 4:01 pm IST
Market Cap
₹11.15 Cr
Return on Equity (ROE)
8.77
PE Ratio (TTM)
0Return on capital employed (ROCE)
11.55
Beta (LTM)
0.64
P/B Ratio
3.11
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-44.29
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Unjha Formulations Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 11.15 | 42.83% | 0.00 | NA | 13 | |
BUY | 8,080.46 | 8.35% | 0.60 | 78 | 1,286 | |
NA | 10.41 | -10.65% | 0.50 | -2 | 35 | |
NA | 1,699.52 | 192.71% | 0.51 | 49 | 465 | |
NA | 1,754.97 | 4.93% | 0.74 | 28 | 311 |
Search interest for Unjha Formulations Ltd Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:7% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Unjha Formulations Ltd.
Unjha Formulations Ltd’s net profit fell -44.29% since last year same period to ₹0.39Cr in the Q1 2025-2026. On a quarterly growth basis, Unjha Formulations Ltd has generated 195.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Unjha Formul. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 3 years, Unjha Formul. stock has moved up by 176.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 36.93% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 11.9% return, outperforming this stock by 31.5%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 63.08% of holdings in Jun 2025 quarter
Organisation | Unjha Formulations Ltd |
Headquarters | Patan |
Industry | Pharmaceuticals |
CEO | Jashodaben S Patel |
E-voting on shares | Click here to vote |
Unjha Formulations Ltd share price today stands at ₹25.2 as on at the close of the market. Unjha Formulations Ltd share today touched a day high of ₹25.95 and a low of ₹24.21.
Unjha Formulations Ltd touched a 52 week high of ₹39 and a 52 week low of ₹19.99. Unjha Formulations Ltd share price today i.e. is closed at ₹25.2, which is -35.38% down from its 52 week high and 26.06% up from its 52 week low.
Unjha Formulations Ltd market capitalisation is ₹11.15 Cr as on .
To buy Unjha Formulations Ltd shares, you need to follow these steps:
Unjha Formulations Ltd trading volume is 13.28K as on . This means that 13.28K shares of Unjha Formulations Ltd were bought and sold on the stock market during today's trading session.